ARDX Competitors & Alternatives
Compare Ardelyx Inc with similar stocks in the same industry
Biotechnology
ARDX
Main Stock$4.98
Tradestie Score
60
Market Cap
$1.29B
Revenue Growth
0.3%
Analyst Upside
+227.3%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$8.13
|
$1.29B | 115.4 | 60 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.56
|
$1.29B | - | 59 | Compare |
|
ZYME
Zymeworks Inc.
|
$21.81
|
$1.28B | - | 49 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.16
|
$1.27B | - | 59 | Compare |
|
SION
Sionna Therapeutics, Inc. Common Stock
|
$49.26
|
$1.26B | - | 51 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 58 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.18
|
$1.22B | - | 55 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.61
|
$1.18B | - | 60 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$58.04
|
$1.17B | - | 52 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$20.77
|
$1.15B | 3.3 | 49 | Compare |
More ARDX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry